Molecular Multi-Target Approach for Human Acetylcholinesterase, Butyrylcholinesterase and β-Secretase 1: Next Generation for Alzheimer’s Disease Treatment

Alzheimer’s Disease (AD) is a neurodegenerative condition characterized by progressive memory loss and other affected cognitive functions. Pharmacological therapy of AD relies on inhibitors of the enzymes acetylcholinesterase (AChE) and butyrylcholinesterase (BChE), offering only a palliative effect...

Descripción completa

Detalles Bibliográficos
Autores principales: Mendes, Géssica Oliveira, Pita, Samuel Silva da Rocha, de Carvalho, Paulo Batista, da Silva, Michel Pires, Taranto, Alex Gutterres, Leite, Franco Henrique Andrade
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10302529/
https://www.ncbi.nlm.nih.gov/pubmed/37375827
http://dx.doi.org/10.3390/ph16060880

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10302529/
https://www.ncbi.nlm.nih.gov/pubmed/37375827
http://dx.doi.org/10.3390/ph16060880

Ejemplares similares